Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tissue factor and thrombin in sickle cell anemia.

Literature DB >> 22398014

Tissue factor and thrombin in sickle cell anemia.

Pichika Chantrathammachart¹, Rafal Pawlinski.

Abstract

Sickle cell anemia is an inherited hematologic disorder associated with hemolytic and vaso-occlusive complications. An activation of coagulation is also a prominent feature of sickle cell anemia. Growing evidence indicates that coagulation may contribute to the inflammation and vascular injury in sickle cell anemia. This review focuses on tissue factor expression and its contribution to the activation of coagulation, thrombosis and vascular inflammation in sickle cell anemia.

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Thromboplastin
Thrombin

Year: 2012 PMID： 22398014 PMCID： PMC3335974 DOI： 10.1016/j.thromres.2012.02.038

Source DB: PubMed Journal: Thromb Res ISSN： 0049-3848 Impact factor: 3.944

31 in total

1. P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease.

Authors: Renata Polanowska-Grabowska; Kori Wallace; Joshua J Field; Lanlin Chen; Melissa A Marshall; Robert Figler; Adrian R L Gear; Joel Linden
Journal: Arterioscler Thromb Vasc Biol Date: 2010-11-11 Impact factor: 8.311

2. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children.

Authors: Denis F Noubouossie; Phu Quoc Lê; Francis Corazza; France Debaugnies; Laurence Rozen; Alina Ferster; Anne Demulder
Journal: Am J Hematol Date: 2011-11-04 Impact factor: 10.047

3. Pulmonary thrombotic arteriopathy in patients with sickle cell disease.

Authors: M O Adedeji; J Cespedes; K Allen; C Subramony; M D Hughson
Journal: Arch Pathol Lab Med Date: 2001-11 Impact factor: 5.534

4. Endothelial nitric oxide synthase and nitric oxide regulate endothelial tissue factor expression in vivo in the sickle transgenic mouse.

Authors: Anna Solovey; Rahn Kollander; Liming Chang Milbauer; Fuad Abdulla; Yingie Chen; Robert J Kelm; Robert P Hebbel
Journal: Am J Hematol Date: 2010-01 Impact factor: 10.047

Review 5. Sickle-cell disease.

Authors: David C Rees; Thomas N Williams; Mark T Gladwin
Journal: Lancet Date: 2010-12-03 Impact factor: 79.321

Review 6. Thrombosis and sickle cell disease.

Authors: Lucia De Franceschi; Maria Domenica Cappellini; Oliviero Olivieri
Journal: Semin Thromb Hemost Date: 2011-03-31 Impact factor: 4.180

7. Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S.

Authors: Felicity N E Gavins; Janice Russell; Elena L Senchenkova; Lidiana De Almeida Paula; Amílcar S Damazo; Charles T Esmon; Daniel Kirchhofer; Robert P Hebbel; D Neil Granger
Journal: Blood Date: 2011-02-08 Impact factor: 22.113

8. A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction.

Authors: Carolyn Hoppe; Frans Kuypers; Sandra Larkin; Ward Hagar; Elliott Vichinsky; Lori Styles
Journal: Br J Haematol Date: 2011-04-08 Impact factor: 6.998

9. The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice.

Authors: Robert P Hebbel; Gregory M Vercellotti; Betty S Pace; Anna N Solovey; Rahn Kollander; Chine F Abanonu; Julia Nguyen; Julie V Vineyard; John D Belcher; Fuad Abdulla; Shadé Osifuye; John W Eaton; Robert J Kelm; Arne Slungaard
Journal: Blood Date: 2010-01-06 Impact factor: 22.113

10. A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis.

Authors: Robert P Hebbel; Greg Vercellotti; Karl A Nath
Journal: Cardiovasc Hematol Disord Drug Targets Date: 2009-12

3 in total